Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults

Herpes simplex virus (HSV) remains latent in nerve root ganglia of infected persons and is thought to reactivate several times yearly. Recent in situ data show the localization of HSV-specific CD8(+) T cells at the dermal epidermal junction next to peripheral sensory nerve endings, suggesting that v...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Journal of infectious diseases Ročník 198; číslo 8; s. 1141
Hlavní autori:	Mark, Karen E, Wald, Anna, Magaret, Amalia S, Selke, Stacy, Olin, Laura, Huang, Meei-Li, Corey, Lawrence
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 15.10.2008
Predmet:	Adult Aged Antibodies, Viral - blood Female Genitalia - virology Herpes Genitalis - immunology Herpes Genitalis - virology Herpes Simplex - immunology Herpes Simplex - virology Herpesvirus 1, Human - immunology Herpesvirus 1, Human - physiology Herpesvirus 2, Human - immunology Herpesvirus 2, Human - physiology Humans Immunocompetence Male Middle Aged Mouth Mucosa - virology Time Factors Virus Activation - immunology Virus Shedding
ISSN:	0022-1899
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Herpes simplex virus (HSV) remains latent in nerve root ganglia of infected persons and is thought to reactivate several times yearly. Recent in situ data show the localization of HSV-specific CD8(+) T cells at the dermal epidermal junction next to peripheral sensory nerve endings, suggesting that viral reactivation may occur more frequently than previously appreciated. Twenty-five HSV-2-seropositive and 18 HSV-1-seropositive healthy adults collected anogenital and oral swabs, respectively, 4 times per day for 60 days. Swabs were assayed for HSV, using a quantitative polymerase chain reaction assay. Twenty-four percent of anogenital reactivations and 21% of oral reactivations lasted < or =6 h, and 49% of anogenital reactivations and 39% of oral reactivations lasted < or =12 h. Lesions were reported in only 3 (7%) of 44 anogenital reactivations and 1 (8%) of 13 oral reactivations lasting < or =12 h. The median HSV DNA levels at initial and last detection were 10(3.5) and 10(3.3) copies/mL, respectively, during anogenital reactivation and 10(3.7) and 10(3.0) copies/mL, respectively, during oral reactivation. This high frequency of short subclinical HSV reactivation in immunocompetent hosts strongly suggests that the peripheral mucosal immune system plays a critical role in clearing HSV reactivations.
AbstractList	Herpes simplex virus (HSV) remains latent in nerve root ganglia of infected persons and is thought to reactivate several times yearly. Recent in situ data show the localization of HSV-specific CD8(+) T cells at the dermal epidermal junction next to peripheral sensory nerve endings, suggesting that viral reactivation may occur more frequently than previously appreciated.BACKGROUNDHerpes simplex virus (HSV) remains latent in nerve root ganglia of infected persons and is thought to reactivate several times yearly. Recent in situ data show the localization of HSV-specific CD8(+) T cells at the dermal epidermal junction next to peripheral sensory nerve endings, suggesting that viral reactivation may occur more frequently than previously appreciated.Twenty-five HSV-2-seropositive and 18 HSV-1-seropositive healthy adults collected anogenital and oral swabs, respectively, 4 times per day for 60 days. Swabs were assayed for HSV, using a quantitative polymerase chain reaction assay.METHODSTwenty-five HSV-2-seropositive and 18 HSV-1-seropositive healthy adults collected anogenital and oral swabs, respectively, 4 times per day for 60 days. Swabs were assayed for HSV, using a quantitative polymerase chain reaction assay.Twenty-four percent of anogenital reactivations and 21% of oral reactivations lasted < or =6 h, and 49% of anogenital reactivations and 39% of oral reactivations lasted < or =12 h. Lesions were reported in only 3 (7%) of 44 anogenital reactivations and 1 (8%) of 13 oral reactivations lasting < or =12 h. The median HSV DNA levels at initial and last detection were 10(3.5) and 10(3.3) copies/mL, respectively, during anogenital reactivation and 10(3.7) and 10(3.0) copies/mL, respectively, during oral reactivation.RESULTSTwenty-four percent of anogenital reactivations and 21% of oral reactivations lasted < or =6 h, and 49% of anogenital reactivations and 39% of oral reactivations lasted < or =12 h. Lesions were reported in only 3 (7%) of 44 anogenital reactivations and 1 (8%) of 13 oral reactivations lasting < or =12 h. The median HSV DNA levels at initial and last detection were 10(3.5) and 10(3.3) copies/mL, respectively, during anogenital reactivation and 10(3.7) and 10(3.0) copies/mL, respectively, during oral reactivation.This high frequency of short subclinical HSV reactivation in immunocompetent hosts strongly suggests that the peripheral mucosal immune system plays a critical role in clearing HSV reactivations.CONCLUSIONSThis high frequency of short subclinical HSV reactivation in immunocompetent hosts strongly suggests that the peripheral mucosal immune system plays a critical role in clearing HSV reactivations. Herpes simplex virus (HSV) remains latent in nerve root ganglia of infected persons and is thought to reactivate several times yearly. Recent in situ data show the localization of HSV-specific CD8(+) T cells at the dermal epidermal junction next to peripheral sensory nerve endings, suggesting that viral reactivation may occur more frequently than previously appreciated. Twenty-five HSV-2-seropositive and 18 HSV-1-seropositive healthy adults collected anogenital and oral swabs, respectively, 4 times per day for 60 days. Swabs were assayed for HSV, using a quantitative polymerase chain reaction assay. Twenty-four percent of anogenital reactivations and 21% of oral reactivations lasted < or =6 h, and 49% of anogenital reactivations and 39% of oral reactivations lasted < or =12 h. Lesions were reported in only 3 (7%) of 44 anogenital reactivations and 1 (8%) of 13 oral reactivations lasting < or =12 h. The median HSV DNA levels at initial and last detection were 10(3.5) and 10(3.3) copies/mL, respectively, during anogenital reactivation and 10(3.7) and 10(3.0) copies/mL, respectively, during oral reactivation. This high frequency of short subclinical HSV reactivation in immunocompetent hosts strongly suggests that the peripheral mucosal immune system plays a critical role in clearing HSV reactivations.
Author	Magaret, Amalia S Corey, Lawrence Olin, Laura Mark, Karen E Huang, Meei-Li Selke, Stacy Wald, Anna
Author_xml	– sequence: 1 givenname: Karen E surname: Mark fullname: Mark, Karen E email: kmark@u.washington.edu organization: Department of Medicine, University of Washington, Seattle, Washington 98122, USA. kmark@u.washington.edu – sequence: 2 givenname: Anna surname: Wald fullname: Wald, Anna – sequence: 3 givenname: Amalia S surname: Magaret fullname: Magaret, Amalia S – sequence: 4 givenname: Stacy surname: Selke fullname: Selke, Stacy – sequence: 5 givenname: Laura surname: Olin fullname: Olin, Laura – sequence: 6 givenname: Meei-Li surname: Huang fullname: Huang, Meei-Li – sequence: 7 givenname: Lawrence surname: Corey fullname: Corey, Lawrence
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/18783315$$D View this record in MEDLINE/PubMed
BookMark	eNo1kEtLxDAYRbMYcWZ8_ATJyl01aZo0WcrgCwYEUVyWTPIVI00Tk3Rw_r0FR7hw7uJwF3eNFmMYAaFLSm4okeKWK6ooW6AVIXVdUanUEq1z_iKENEy0p2hJZSsZo3yFPl51dHY4YDOATmAxRJeDhYxDjz8hxbll5-MAP3jv0pRxAm2K2-viwojdHO-nMZjgIxQYC9Z2Gko-Rye9HjJcHHmG3h_u3zZP1fbl8Xlzt61Mw3mpmBY7IIJKSrS1HIywtGe6oZIb0gpb9yCV5py0jAljyOxTQbRuiKrb1u7qM3T9txtT-J4gl867bGAY9Ahhyp1QXKqaN7N4dRSnnQfbxeS8Tofu_4r6FyufX4s
CitedBy_id	crossref_primary_10_1172_JCI57148 crossref_primary_10_1080_00480169_2013_768151 crossref_primary_10_1093_infdis_jiw091 crossref_primary_10_2460_ajvr_73_7_1079 crossref_primary_10_1016_j_jiac_2021_07_015 crossref_primary_10_1111_all_14762 crossref_primary_10_1016_S1773_035X_21_00069_1 crossref_primary_10_1186_s12916_019_1285_x crossref_primary_10_1097_QCO_0000000000000029 crossref_primary_10_1128_JVI_01606_20 crossref_primary_10_1136_sextrans_2024_056307 crossref_primary_10_1007_s13365_011_0063_0 crossref_primary_10_1097_QAI_0000000000002641 crossref_primary_10_1186_1471_2334_14_63 crossref_primary_10_1038_s41598_018_37833_8 crossref_primary_10_1128_AAC_03875_14 crossref_primary_10_1371_journal_pone_0146186 crossref_primary_10_1007_s11908_011_0209_5 crossref_primary_10_2217_fvl_2017_0082 crossref_primary_10_1007_s00520_014_2152_0 crossref_primary_10_1007_s13365_021_01012_9 crossref_primary_10_1128_JVI_01237_12 crossref_primary_10_1136_medethics_2012_100894 crossref_primary_10_1038_nm_3103 crossref_primary_10_1093_infdis_jiv451 crossref_primary_10_1016_j_jinf_2012_10_011 crossref_primary_10_1016_j_virol_2017_06_031 crossref_primary_10_1016_j_antiviral_2021_105103 crossref_primary_10_1111_j_1471_0528_2010_02785_x crossref_primary_10_1002_rmv_2491 crossref_primary_10_1093_infdis_jiq035 crossref_primary_10_1155_2014_258291 crossref_primary_10_3390_v13122395 crossref_primary_10_1016_j_virol_2011_06_027 crossref_primary_10_1097_QAD_0000000000001542 crossref_primary_10_1097_QAD_0b013e32835cb927 crossref_primary_10_1016_j_bpobgyn_2014_07_015 crossref_primary_10_1097_QAI_0b013e31824bed3f crossref_primary_10_1038_nm_2006 crossref_primary_10_1097_QAI_0b013e3181d91322 crossref_primary_10_1146_annurev_micro_092412_155654 crossref_primary_10_2460_ajvr_80_5_490 crossref_primary_10_3389_fmicb_2021_825049 crossref_primary_10_1111_bpa_13044 crossref_primary_10_1097_OLQ_0000000000000522 crossref_primary_10_1172_JCI132583 crossref_primary_10_3389_fimmu_2021_735643 crossref_primary_10_1126_scitranslmed_aad6654 crossref_primary_10_1016_S0140_6736_11_61750_9 crossref_primary_10_3389_fmicb_2017_02342 crossref_primary_10_1111_j_1708_8240_2011_00469_x crossref_primary_10_1016_j_jaut_2022_102950 crossref_primary_10_1097_QAI_0b013e31821acb5 crossref_primary_10_1111_j_1600_0757_2009_00308_x crossref_primary_10_1155_2013_369172 crossref_primary_10_1016_j_vaccine_2013_08_066 crossref_primary_10_1007_s11262_015_1231_8 crossref_primary_10_1128_JVI_01721_18 crossref_primary_10_1016_j_jcv_2017_11_004 crossref_primary_10_1097_OLQ_0000000000002030 crossref_primary_10_1111_tid_14335 crossref_primary_10_1177_039463200902200324 crossref_primary_10_1038_mtna_2013_75 crossref_primary_10_1128_CMR_00043_15 crossref_primary_10_1111_j_1525_1446_2010_00931_x crossref_primary_10_1111_j_1600_0757_2010_00361_x crossref_primary_10_2217_fvl_10_35 crossref_primary_10_1016_j_jcv_2019_01_001 crossref_primary_10_1128_JVI_01302_12 crossref_primary_10_1007_s11908_009_0066_7 crossref_primary_10_3390_diagnostics13101798 crossref_primary_10_1371_journal_pone_0114652 crossref_primary_10_1016_j_vaccine_2017_10_084 crossref_primary_10_1002_jmv_23634 crossref_primary_10_1002_jmv_24965 crossref_primary_10_1007_s11908_009_0020_8 crossref_primary_10_1093_ofid_ofab218 crossref_primary_10_1186_s12985_025_02786_8 crossref_primary_10_1016_j_coviro_2017_03_010 crossref_primary_10_1128_AAC_01114_13 crossref_primary_10_1097_OLQ_0000000000000022 crossref_primary_10_3390_medicina60020284 crossref_primary_10_1016_j_addr_2014_12_005 crossref_primary_10_1136_jclinpath_2014_202668 crossref_primary_10_1111_imr_12672 crossref_primary_10_1128_JVI_00939_09 crossref_primary_10_1371_journal_pone_0214151 crossref_primary_10_2460_ajvr_77_10_1140 crossref_primary_10_1016_j_virol_2017_11_010 crossref_primary_10_1016_j_ejmech_2022_114443 crossref_primary_10_1007_s00129_015_3769_x crossref_primary_10_1016_j_virol_2023_109907 crossref_primary_10_1093_infdis_jiy631 crossref_primary_10_1093_infdis_jiz203 crossref_primary_10_1097_OLQ_0b013e3181bc9a2f crossref_primary_10_2471_BLT_19_237149 crossref_primary_10_1371_journal_pcbi_1003922 crossref_primary_10_3390_v6020371 crossref_primary_10_7554_eLife_00288 crossref_primary_10_1002_jmv_21903 crossref_primary_10_1093_infdis_jir314 crossref_primary_10_1093_infdis_jir317 crossref_primary_10_1111_1346_8138_16229 crossref_primary_10_1371_journal_pcbi_1009072 crossref_primary_10_3389_fimmu_2023_1207544 crossref_primary_10_1038_s41423_019_0359_1 crossref_primary_10_1097_IPC_0000000000000481 crossref_primary_10_1086_591914 crossref_primary_10_1172_JCI179483 crossref_primary_10_1186_s12985_023_02157_1 crossref_primary_10_1128_JVI_01574_18 crossref_primary_10_1093_infdis_jiv495 crossref_primary_10_1136_sextrans_2016_052811 crossref_primary_10_1371_journal_pone_0005272 crossref_primary_10_1097_OLQ_0b013e3181c17b65 crossref_primary_10_1111_prd_12010 crossref_primary_10_1097_OLQ_0b013e3181d3d023 crossref_primary_10_1128_jvi_00669_23 crossref_primary_10_1186_1743_422X_7_328 crossref_primary_10_1093_infdis_jiaf157 crossref_primary_10_1126_scitranslmed_3000193 crossref_primary_10_1186_s13567_020_00749_1 crossref_primary_10_1016_j_epidem_2010_08_003 crossref_primary_10_1111_imr_12650 crossref_primary_10_1073_pnas_1006614107 crossref_primary_10_1016_j_vaccine_2018_02_067 crossref_primary_10_1186_2045_3701_1_24 crossref_primary_10_1111_jgs_14090 crossref_primary_10_1016_j_exer_2010_03_001 crossref_primary_10_1093_infdis_jiz225 crossref_primary_10_1097_OLQ_0b013e3181f0bafb crossref_primary_10_1002_ajmg_b_31234 crossref_primary_10_1177_0956462414546504 crossref_primary_10_1007_s12160_014_9640_9 crossref_primary_10_1128_CVI_00333_10 crossref_primary_10_1128_AAC_02675_15 crossref_primary_10_1093_cid_ciy562 crossref_primary_10_1002_jcph_70102 crossref_primary_10_1016_j_micpath_2012_11_001 crossref_primary_10_1016_j_jcv_2014_11_003 crossref_primary_10_1093_infdis_jix679 crossref_primary_10_1007_s13346_017_0389_0 crossref_primary_10_1016_j_ejogrb_2021_01_055 crossref_primary_10_1126_scitranslmed_3002329 crossref_primary_10_1097_OLQ_0b013e3181d4f866 crossref_primary_10_1016_j_pop_2010_04_003 crossref_primary_10_4049_jimmunol_1800471 crossref_primary_10_1111_j_1574_6976_2011_00320_x crossref_primary_10_1586_14760584_2014_932694 crossref_primary_10_1007_s13365_016_0485_9 crossref_primary_10_1016_j_jcv_2015_07_006 crossref_primary_10_1128_JVI_00227_19 crossref_primary_10_2217_fvl_11_28 crossref_primary_10_1128_JVI_03285_13 crossref_primary_10_1093_ofid_ofy295 crossref_primary_10_1097_OLQ_0b013e3181a4f6ac crossref_primary_10_1126_science_1254803 crossref_primary_10_1093_jac_dkr346 crossref_primary_10_1002_jmv_28603 crossref_primary_10_1093_jpids_piv021 crossref_primary_10_1371_journal_pone_0155124 crossref_primary_10_3390_v16071019 crossref_primary_10_3390_v17050600 crossref_primary_10_1111_j_1600_0897_2009_00768_x crossref_primary_10_1097_GCO_0b013e3283294840 crossref_primary_10_1111_1346_8138_13506 crossref_primary_10_3389_fcimb_2018_00177 crossref_primary_10_1038_nature12110 crossref_primary_10_1093_infdis_jiv148 crossref_primary_10_1089_aid_2014_0207 crossref_primary_10_1016_j_vetmic_2021_109001 crossref_primary_10_1586_erv_12_129
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1086/591913
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Biology
ExternalDocumentID	18783315
Genre	Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NIAID NIH HHS grantid: K24 AI071113 – fundername: NIAID NIH HHS grantid: P01 AI30731 – fundername: NIAID NIH HHS grantid: R37 AI042528 – fundername: NIAID NIH HHS grantid: R37 AI42528 – fundername: NIAID NIH HHS grantid: T32 AI007044 – fundername: NIAID NIH HHS grantid: K23 AI071257 – fundername: NIAID NIH HHS grantid: P01 AI030731 – fundername: NIAID NIH HHS grantid: T32 AI07044
GroupedDBID	--- -DZ -~X ..I .2P .I3 .XZ .ZR 08P 0R~ 123 1TH 29K 2AX 2WC 36B 4.4 48X 53G 5GY 5RE 5VS 5WD 70D 85S AABZA AACGO AACZT AAHBH AAHTB AAJKP AAJQQ AAMVS AANCE AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWTL ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPEJ ABPLY ABPPZ ABPQP ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACGFO ACGFS ACGOD ACHIC ACPRK ACUFI ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFZL AFIYH AFOFC AFXAL AFYAG AGINJ AGKEF AGORE AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BR6 BTRTY BVRKM C45 CDBKE CGR CS3 CUY CVF CZ4 D-I DAKXR DCCCD DIK DILTD DU5 D~K EBS ECGQY ECM EE~ EIF EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HQ3 HTVGU HW0 HZ~ IH2 IOX IPSME J21 JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B LSO LU7 MHKGH MJL ML0 N4W N9A NGC NOMLY NOYVH NPM NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TR2 W2D W8F WH7 X7H YAYTL YKOAZ YXANX ~91 7X8
ID	FETCH-LOGICAL-c455t-3a6be061810add5ec6d1f3a4185c076d2fe89a5507336cc03a6160aa409277db2
IEDL.DBID	7X8
ISICitedReferencesCount	199
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000259891800008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0022-1899
IngestDate	Sat Sep 27 22:28:36 EDT 2025 Mon Jul 21 05:47:00 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	8
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c455t-3a6be061810add5ec6d1f3a4185c076d2fe89a5507336cc03a6160aa409277db2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://academic.oup.com/jid/article-pdf/198/8/1141/18055155/198-8-1141.pdf
PMID	18783315
PQID	69589254
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_69589254 pubmed_primary_18783315
PublicationCentury	2000
PublicationDate	2008-10-15
PublicationDateYYYYMMDD	2008-10-15
PublicationDate_xml	– month: 10 year: 2008 text: 2008-10-15 day: 15
PublicationDecade	2000
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	The Journal of infectious diseases
PublicationTitleAlternate	J Infect Dis
PublicationYear	2008
References	18783317 - J Infect Dis. 2008 Oct 15;198(8):1098-100. doi: 10.1086/591914.
References_xml	– reference: 18783317 - J Infect Dis. 2008 Oct 15;198(8):1098-100. doi: 10.1086/591914.
SSID	ssj0004367
Score	2.4097505
Snippet	Herpes simplex virus (HSV) remains latent in nerve root ganglia of infected persons and is thought to reactivate several times yearly. Recent in situ data show...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1141
SubjectTerms	Adult Aged Antibodies, Viral - blood Female Genitalia - virology Herpes Genitalis - immunology Herpes Genitalis - virology Herpes Simplex - immunology Herpes Simplex - virology Herpesvirus 1, Human - immunology Herpesvirus 1, Human - physiology Herpesvirus 2, Human - immunology Herpesvirus 2, Human - physiology Humans Immunocompetence Male Middle Aged Mouth Mucosa - virology Time Factors Virus Activation - immunology Virus Shedding
Title	Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults
URI	https://www.ncbi.nlm.nih.gov/pubmed/18783315 https://www.proquest.com/docview/69589254
Volume	198
WOSCitedRecordID	wos000259891800008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Na9wwEB022aTk0uajTdM2iQ65mliSJUsQCKV06aG7hJCQvS2yPsAQ1u56s2T_fUdeG3IJOQSEEdgCMR6N3nis9wAuCplRHQJPgjIhyRSuOe1YkbTkc0w4J03Lrv83n0zUdKpvBnDVn4WJv1X2MbEN1K6y8Rv5pdRCacxmrut_SdSMirXVTkBjC4YcgUz06Xz6giucy7znCqeYVrxQFhIa0xT-OqhsN5fRp_dNax8-dqCS_Nx4wQEM_PwQdjcyk-tD-DDuCuhH8HBr6tI9romNchHeEV-XTeV8Q6pA8PXV2GvKyBj8TFbl4qkhCCptL4FGSmzxQEllO7i9JC2BR_MZ7ke_7379STpthcRmQiwTbmThcS9XNMUIJ7yVjgZuIpWNTXPpWPBKm0h2xrm0NsXnqUyNwXSQ5bkr2BfYnldz_xUIQi5mDd7TgmVGMpUWGH2py6wWwVN3Aue96Wbou7EgYea-empmvfFO4Hhj_Vm9odiYUZUrzqn49ubY77DHOopaKn7AMOCq9aewY1fLslmctS6B18nN-D9yUsH7
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapidly+cleared+episodes+of+herpes+simplex+virus+reactivation+in+immunocompetent+adults&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Mark%2C+Karen+E&rft.au=Wald%2C+Anna&rft.au=Magaret%2C+Amalia+S&rft.au=Selke%2C+Stacy&rft.date=2008-10-15&rft.issn=0022-1899&rft.volume=198&rft.issue=8&rft.spage=1141&rft_id=info:doi/10.1086%2F591913&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon